Stéfan Halbherr


Stéfan Halbherr is one of five founders of the start-up company InnoMedica and has led the Research and Development department since the beginning 4 years ago. He studied biochemistry and immunology and holds a PhD degree from the University of Berne (Switzerland).

With a dedicated team and a 22-people-strong company he aims at bridging the gap between innovative medicine and patient’s needs. He developed a unique industrial scale GMP manufacturing process for ultra-small liposomes with novel biological properties.

This process enabled the research of pipeline products that today cover the areas of nano-chemotherapy and image guided surgery in oncology, neurodegenerative diseases, and bacteriology. With the first product Talidox moving into phase 1 testing a major milestone has been achieved.

dont miss

Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration

Ultra-small liposomes of 30nm in size give rise to unknown pharmacological effects. Talidox (Targeted Liposomal Doxorubicin) accumulates chemotherapeutic drug in cancer tissue and minimizes its side effects. Using the nano-shuttle, near-infrared dye is specifically transported to tumors and can assist during fluorescence-guided surgery. Talineuren (Targeted Liposomal Neuroregenerator) delivers neuroprotective GM1 ganglioside to the brain after oral intake, thereby e.g. elevating dopamine levels in the striatum in Parkinson models of disease.


  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Nirmesh Patel: Speaking at the Oncology Convention

    Nirmesh Patel
    Cambridge Cancer Genomics

    Monitoring cancer evolution through smart genomics and liquid biopsies

  • Emlyn Samuel: Speaking at the Oncology Convention

    Emlyn Samuel
    Cancer Research UK

    Brexit: getting the best outcome for research and patients

  • Sam Janes: Speaking at the Oncology Convention

    Sam Janes

    Early Detection of Lung Cancer

  • Merina Ahmed: Speaking at the Oncology Convention

    Merina Ahmed
    Royal Marsden NHS foundation Trust

    Stereotactic Radiotherapy for lung tumours and oligometastatic disease